|
RNF19B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.799500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.443920E-03 |
| Normal-vs-Stage2 |
4.689900E-02 |
| Normal-vs-Stage3 |
8.044200E-02 |
| Normal-vs-Stage4 |
6.600400E-02 |
| Stage1-vs-Stage2 |
5.777000E-01 |
| Stage1-vs-Stage3 |
3.482400E-01 |
| Stage1-vs-Stage4 |
9.905600E-01 |
| Stage2-vs-Stage3 |
8.215400E-01 |
| Stage2-vs-Stage4 |
7.310000E-01 |
| Stage3-vs-Stage4 |
6.150200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.860900E-03 |
| Normal-vs-AfricanAmerican |
1.958750E-04 |
| Normal-vs-Asian |
3.084600E-01 |
| Caucasian-vs-AfricanAmerican |
1.496580E-01 |
| Caucasian-vs-Asian |
8.280200E-01 |
| AfricanAmerican-vs-Asian |
4.308400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.972760E-04 |
| Normal-vs-Female |
1.426600E-01 |
| Male-vs-Female |
2.415700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.459870E-03 |
| Normal-vs-Extreme_Weight |
1.91765999999483E-05 |
| Normal-vs-Obese |
1.903890E-02 |
| Normal-vs-Extreme_Obese |
1.273960E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.171200E-01 |
| Normal_Weight-vs-Obese |
2.221200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.821400E-01 |
| Extreme_Weight-vs-Obese |
9.001600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.963000E-01 |
| Obese-vs-Extreme_Obese |
9.098800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.458200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.037500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.143700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.888000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.118000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.442400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.315600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.986000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.551200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.476200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.57910000000627E-05 |
| Normal-VS-Type2 PRCC |
1.236960E-01 |
| Normal-VS-KIRP CIMP |
2.394200E-01 |
| Normal-VS-Unclassified PRCC |
5.451700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.007800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.790400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.107350E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.571700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.674000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.487800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.197600E-02 |
| Normal-vs-N1 |
9.395600E-02 |
| Normal-vs-N2 |
3.126800E-01 |
| N0-vs-N1 |
8.750200E-01 |
| N0-vs-N2 |
9.907000E-01 |
| N1-vs-N2 |
9.424200E-01 |
|
|
